Latka logo

2024 Revenue

$21.1M(Est.)

Team

115

Founded

2010

Sanguine Biosciences Revenue (2024)

Sanguine Biosciences generated an estimated $21.1M in annual revenue in 2024. Source: GetLatka estimate

Company empowering patients with their health care data and facilitating patient participation in biomedical research, accelerating the personalized-medicine research options

Last updated

Sanguine Biosciences Revenue

In 2024, Sanguine Biosciences's revenue reached $21.1M.

Sanguine Biosciences Revenue GrowthReported revenue / ARR over time · latest figure estimated$0$5M$10M$15M$20M$25M20102012201420162018202020222024$0$21.1MSource: GetLatka.com
YearMilestoneSource
2024Sanguine Biosciences Hit $21.1m revenue in June 2024Estimated
2010Launched with $0 revenue

Sanguine Biosciences Employees & Team Size

Sanguine Biosciences employs approximately 115 people as of 2026.

Sanguine Biosciences Team GrowthReported headcount over time02550751001252010201220142016201820202022202400115115Source: GetLatka.com
YearMilestoneSource
2024Reached 115 employees (December 2024)Not recorded
2024Reached 119 employees (July 2024)Not recorded

Frequently Asked Questions about Sanguine Biosciences

What is Sanguine Biosciences's revenue?

As of 2024, Sanguine Biosciences generated an estimated $21.1M in annual revenue.

Who founded Sanguine Biosciences?

Sanguine Biosciences was founded by Brian Neman.

When was Sanguine Biosciences founded?

Sanguine Biosciences was founded in 2010.

Who is the CEO of Sanguine Biosciences?

The CEO of Sanguine Biosciences is Brian Neman.

How many employees does Sanguine Biosciences have?

As of 2024, Sanguine Biosciences had 115 employees.

Where is Sanguine Biosciences headquartered?

Sanguine Biosciences is headquartered in Woburn, Massachusetts, United States.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile